Trials / Recruiting
RecruitingNCT07093606
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eltrombopag | ITP patients will receive Eltrombopag and evulate occurance of liver disordres . |
Timeline
- Start date
- 2025-07-14
- Primary completion
- 2026-01-20
- Completion
- 2026-01-20
- First posted
- 2025-07-30
- Last updated
- 2025-07-30
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07093606. Inclusion in this directory is not an endorsement.